TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma

Overview of attention for article published in Frontiers in immunology, May 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 67 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

PROCESSES FOR GENERATING TIL PRODUCTS USING PD-1/TIGIT TALEN DOUBLE KNOCKDOWN

Application WO-2024055018-A1

World Intellectual Property Organisation (WIPO)

PROCESSES FOR GENERATING TIL PRODUCTS USING PD-1/TIGIT TALEN DOUBLE KNOCKDOWN

Application WO-2024055017-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.